companies

Orakl

Founded 2023
Employees 3+
Primary contact
39 rue Camille Desmoulins
94800 Villejuif
Île-de-France
France
Links
https://www.orakl.bio/
Diseases & Conditions
Sections
Technologies
Orakl leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With its platform, the company partners with oncology players to identify relevant targets and deliver new drugs, faster.
Founded 2023
Employees 3+
Primary contact
39 rue Camille Desmoulins
94800 Villejuif
Île-de-France
France
Links
https://www.orakl.bio/
Diseases & Conditions
Sections
Technologies

Funding 💰

Select investors Bpifrance, WILCO, Agoranov, MATWIN

Key people 🧑‍🤝‍🧑

Highlights ⭐

  • Prominent partner: Orakl's partnership with the globally renowned Gustave Roussy, the world's 3rd best cancer center, gives the company a significant advantage in terms of data access.
  • Best-in-class biology: Orakl's tumor models mimic real-life responses to drugs. They result from the exclusive know-how from more than 28 years of combined R&D.
  • Deep patient data: Orakl matches its tumor models with detailed clinical and omics data. This provides the necessary context to interpret biological results.
  • AI-powered analysis: The company gathers unique insights by mining multi-modal experimental data and combining it with deep patient data.
Last update: June 4, 2023